Additional studies showed that anti-CD47 treatment repolarized GAMs in vivo to an M1 phenotype and that both M1- and M2-polarized MΦ alike displayed a higher GBM cell phagocytosis rate under anti-CD47 treatment (120). This evidence concerns the gene CD47 and glioblastoma.